Novel organoplatinum(II) complexes with 2-acetylthiophene
thiosemicarbazone
(ATTSC) were synthesized. The reaction of K2PtCl4 with ATTSC in 1:1 and 1:2 metal to ligand ratios yielded 1 [Pt4(ATTSC-2H)4·4DMF] and 2 [Pt(ATTSC-H)(ATTSC)Cl·3CH3OH)]. The crystal structures
of these platinum chelates have been solved by single-crystal X-ray
diffraction structure determinations and revealed metalation of the
thiophene ring at C2 through platinum atoms. Further characterization
of 1 and 2 was performed using electronic,
IR, UV/vis, and NMR spectroscopies and elemental analysis. The in
vitro antitumor activity of the ligand as well as 1 and 2 was determined against two different human tumor cell lines
(HT-29 and HuTu-80). These tests revealed that the platinum(II) complexes
are more cytotoxic than their ligand. The tetranuclear complex 1 shows higher antiproliferative activity (IC50 = 1.2 and 1.5 μM) when compared to 2 (IC50 = 3 and 5.9 μM), while the ligand has IC50 values of 8.6 and >10 μM. Compounds 1 and 2 can therefore be considered as agents with potential antitumor
activity.
The tuning of wetting over an extreme range, from superhydrophilic to superhydrophobic, was demonstrated on 1D Al/AlO nanostructures. While chaotic and tangled 1D Al/AlO nanostructures exhibited complete wetting, they became water repellent (with a water contact angle (CA) ≥173°) after the infiltration of poly[bis(2,2,2-trifluoroethoxy)phosphazene] (PTFEP) solution. This simple strategy allows the achievement of two extreme wetting regimes, perfect wetting and non-wetting, without altering the nanostructured surface topography. The same surface was also found to exhibit repellency towards artificial blood and hexadecane.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.